Atrial overdrive pacing to prevent atrial fibrillation: Insights from ASSERT

被引:41
|
作者
Hohnloser, Stefan H. [1 ]
Healey, Jeff S. [2 ]
Gold, Michael R. [3 ]
Israel, Carsten W. [1 ]
Yang, Sean [2 ]
van Gelder, Isabelle [4 ]
Capucci, Alessandro [5 ]
Lau, Chu P. [6 ]
Fain, Eric [7 ]
Morillo, Carlos A. [1 ]
Ha, Andrew [2 ]
Carlson, Mark [7 ]
Connolly, Stuart J. [2 ]
机构
[1] Goethe Univ Frankfurt, Frankfurt, Germany
[2] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[3] Med Univ S Carolina, Charleston, SC 29425 USA
[4] Univ Groningen, Univ Med Ctr Groningen, Thoraxctr, Groningen, Netherlands
[5] Univ Politecn Marche, Clin Cardiol, Ancona, Italy
[6] St Marys Hosp, Hong Kong, Hong Kong, Peoples R China
[7] St Jude Med, Sylmar, CA USA
关键词
Atrial fibrillation; Pacemaker; Preventive pacing; SINUS-NODE DYSFUNCTION; BRADY-TACHY SYNDROME; RANDOMIZED-TRIAL; TACHYARRHYTHMIAS; ALGORITHMS; EFFICACY; THERAPIES; BURDEN; IMPACT; SUPPRESSION;
D O I
10.1016/j.hrthm.2012.06.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Pacing algorithms to prevent atrial fibrillation (AF) have been tested in studies of modest size and duration with inconclusive results. OBJECTIVES To prospectively evaluate the relationship between subclinical AF and stroke in patients 65 years of age or older with no previous AF receiving a first pacemaker or an implantable cardioverter-defibrillator for standard indications. Three months following device implantation, pacemaker patients were randomized to have continuous atrial overdrive pacing (CAOP) algorithm turned "ON" or "OFF." The primary study outcome was development of electrocardiogram-documented AF >6 minutes. RESULTS A total of 2343 patients were randomized and followed for a mean of 2.5 years. The primary outcome occurred in 60 patients in the CAOP ON group (1.96% per year) and in 45 in the CAOP OFF group (1.44% per year; relative risk 1.38; 95% confidence interval 0.94 -2.03; P = .10). Major clinical events (stroke, myocardial infarct, cardiovascular death, systemic embolism, heart failure hospitalization) occurred at similar frequencies in the 2 groups. In the CAOP ON group, 133 of the 1164 patients (11.4%) crossed over to CAOP OFF compared with 12 of the 1179 (1.0%) who crossed over from OFF to ON (P <.0001). False-positive device detections of AF were more common among patients assigned to CAOP ON (23%) than among patients assigned to CAOP OFF (7.7%; relative risk 2.99; 95% confidence interval 2.40-3.74; P <.001). Pacemaker generator replacement for battery depletion occurred in 4.4% of the subjects randomized to CAOP ON and in 2.5% of the patients assigned to CAOP OFF (relative risk 1.70; 95% confidence interval 1.08-2.67; P = .02). CONCLUSIONS CAOP does not prevent new-onset AF, is poorly tolerated, and accelerates pulse generator battery depletion.
引用
收藏
页码:1667 / 1673
页数:7
相关论文
共 50 条
  • [31] Pacing Therapy for Prevention of Atrial Fibrillation
    Mizutani, Noboru
    JOURNAL OF ARRHYTHMIA, 2005, 21 (04) : 438 - 449
  • [32] Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial
    Stephanie M Fitts
    Michael R.S. Hill
    Rahul Mehra
    Paul Friedman
    Stephen Hammill
    G. Neal Kay
    Atul Prakash
    Charles Webb
    Sanjeev Saksena
    Journal of Interventional Cardiac Electrophysiology, 1998, 2 : 139 - 144
  • [33] Atrial fibrillation:: Stimulation and pacing therapy
    Lewalter, T
    Yang, A
    Bielik, H
    Schrickel, J
    Lüderitz, B
    HERZ, 2002, 27 (04) : 345 - 356
  • [34] Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial
    Fitts, SM
    Hill, MRS
    Mehra, R
    Friedman, P
    Hammill, S
    Kay, GN
    Prakash, A
    Webb, C
    Saksena, S
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 1998, 2 (02) : 139 - 144
  • [35] Atrial septal pacing for the termination of atrial fibrillation: study in a biophysical model of human atria
    Uldry, Laurent
    Virag, Nathalie
    Lindemans, Fred
    Vesin, Jean-Marc
    Kappenberger, Lukas
    EUROPACE, 2012, 14 : V112 - V120
  • [36] Implication of ventricular pacing burden and atrial pacing therapies on the progression of atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials
    Munawar, Dian A.
    Mahajan, Rajiv
    Agbaedeng, Thomas A.
    Thiyagarajah, Anand
    Twomey, Darragh J.
    Khokhar, Kashif
    O'Shea, Catherine
    Young, Glenn D.
    Roberts-Thomson, Kurt C.
    Munawar, Muhammad
    Lau, Dennis H.
    Sanders, Prashanthan
    HEART RHYTHM, 2019, 16 (08) : 1204 - 1214
  • [37] Atrial fibrillation:: profit from cardiac pacing?
    Yang, A
    Lüderitz, B
    Lewalter, T
    ZEITSCHRIFT FUR KARDIOLOGIE, 2005, 94 (03): : 141 - 151
  • [38] Does atrial pacing lead to atrial fibrillation in patients with sick sinus syndrome? Insights from the DANPACE trial
    Hjortsoj, Sren
    Riahi, Sam
    Nielsen, Jens Cosedis
    Skjoth, Flemming
    Lundbye-Christensen, Soren
    Andersen, Henning R.
    EUROPACE, 2014, 16 (02): : 241 - 245
  • [39] Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up
    Gillis, Anne M.
    Morck, Margaret
    Exner, Derek V.
    Sheldon, Robert S.
    Duff, Henry J.
    Mitchell, Brent L.
    Wyse, George D.
    EUROPACE, 2009, 11 (08): : 1041 - 1047
  • [40] Effects of right atrial pacing preference in prevention of paroxysmal atrial fibrillation - Atrial pacing preference study (APP study)
    Ogawa, Hideyuki
    Ishikawa, Toshiyuki
    Matsushita, Kouhei
    Matsumoto, Katsumi
    Ishigami, Tomoaki
    Sugano, Teruyasu
    Uchino, Kazuaki
    Umemura, Satoshi
    Sumita, Shinichi
    Kimura, Kazuo
    Nakagawa, Takeshi
    Shimizu, Makoto
    Nishikawa, Hideo
    Kasai, Atsunobu
    Kioka, Yukio
    CIRCULATION JOURNAL, 2008, 72 (05) : 700 - 704